SMARCB1 and neoplasm: Of them, tumor progression of SMARCB1-deficient sinonasal carcinoma was the most common cause of death (44 patients, 77.2%), followed by unknown causes (7 patients, 12.3%), and cerebrovascular events (6 patients, 10.5%).